483 related articles for article (PubMed ID: 11044431)
1. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
Marra DE; Simoncini T; Liao JK
Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells.
Nathe TJ; Deou J; Walsh B; Bourns B; Clowes AW; Daum G
Arterioscler Thromb Vasc Biol; 2002 Aug; 22(8):1293-8. PubMed ID: 12171790
[TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).
Laufs U; Marra D; Node K; Liao JK
J Biol Chem; 1999 Jul; 274(31):21926-31. PubMed ID: 10419514
[TBL] [Abstract][Full Text] [Related]
5. Anti-sense oligonucleotide of p21(waf1/cip1) prevents interleukin 4-mediated elevation of p27(kip1) in low grade astrocytoma cells.
Liu J; Estes ML; Drazba JA; Liu H; Prayson R; Kondo S; Jacobs BS; Barnett GH; Barna BP
Oncogene; 2000 Feb; 19(5):661-9. PubMed ID: 10698511
[TBL] [Abstract][Full Text] [Related]
6. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cells.
Ishida A; Sasaguri T; Kosaka C; Nojima H; Ogata J
J Biol Chem; 1997 Apr; 272(15):10050-7. PubMed ID: 9092548
[TBL] [Abstract][Full Text] [Related]
7. eNOS inhibition of proliferation: a role for p21(Sdi1/Cip1/Waf1) and p27(kip1).
Holt CM
Cardiovasc Res; 2000 Sep; 47(4):640-1. PubMed ID: 10974212
[No Abstract] [Full Text] [Related]
8. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
9. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
Hupfeld CJ; Weiss RH
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells.
Stuart WD; Maeda S; Khera P; Fagin JA; Clemens TL
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E60-7. PubMed ID: 10893323
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.
Yang Z; Krasnici N; Lüscher TF
Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673
[TBL] [Abstract][Full Text] [Related]
13. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
[TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
[TBL] [Abstract][Full Text] [Related]
15. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
16. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation.
Tian JQ; Quaroni A
Am J Physiol; 1999 Jun; 276(6):C1245-58. PubMed ID: 10362586
[TBL] [Abstract][Full Text] [Related]
17. eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis.
Sato J; Nair K; Hiddinga J; Eberhardt NL; Fitzpatrick LA; Katusic ZS; O'Brien T
Cardiovasc Res; 2000 Sep; 47(4):697-706. PubMed ID: 10974218
[TBL] [Abstract][Full Text] [Related]
18. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869
[TBL] [Abstract][Full Text] [Related]
19. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
